Healthcare Industry Parkinson's Disease Therapeutics Market Trends | Page 3

Your Catalyst To a Lucrative Business
Table of Content of Parkinson's Disease Therapeutics Market
Chapter 1. Executive Summary
Chapter 2. Parkinson’s Disease Therapeutics Market Analysis
2.1. Market Segmentation
2.2. Value Chain Analysis
2.3. Market Drivers and Restraints
2.4. Parkinson’s Disease Therapeutics – Porter’s Analysis
2.5. Parkinson’s Disease Therapeutics – SWOT Analysis
2.6. Parkinson’s Disease Therapeutics - Company Market Share Analysis
Chapter 3. Parkinson’s Disease Therapeutics Market Size, By Product
3.1. Drug Therapy
3.1.1. Dopamine Replacement Therapy (DRT)
3.1.1.1. Global DRT market, 2012 – 2019, (USD Million)
3.1.2. Dopamine Agonists
3.1.2.1. Global dopamine agonists market, 2012 – 2019, (USD Million)
3.1.3. MAO-inhibitors
3.1.3.1. Global MAO-inhibitors market, 2012 – 2019, (USD Million)
3.1.4. COMT-inhibitors
3.1.4.1. Global COMT-inhibitors market, 2012 – 2019, (USD Million)
3.1.5. Others
3.1.5.1. Global other drug therapies market, 2012 – 2019, (USD Million)
3.2. Deep Brain Stimulation Device
3.2.1. Global deep brain stimulation devices market, 2012 – 2019, (USD Million)
3.3. Ablative Neurosurgery
3.3.1. Global ablative neurosurgery market, 2012 – 2019, (USD Million)
3.4. Others
3.4.1. Global other therapies market, 2012 – 2019, (USD Million)
Chapter 4. Parkinson’s Disease Therapeutics Market Size, By Region
4.1. North America
4.1.1. North America Parkinson’s disease therapeutics market, by product, 2012 – 2019, (USD Million)
4.2. Europe
4.2.1. Europe Parkinson’s disease therapeutics market, by product, 2012 – 2019, (USD Million)
Follow Us: